Back
53
Day Range
$87.46
$88.78
52-Week Range
$84.59
$114.44
Volume
1,420,017
50D / 200D Avg
$92.18
/
$95.23
Prev Close
$87.87
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 24.7 | 0.4 |
| P/B | 1.4 | 2.9 |
| ROE % | 5.6 | 3.7 |
| Net Margin % | 8.6 | 3.8 |
| Rev Growth 5Y % | 4.8 | 10.0 |
| D/E | 0.6 | 0.2 |
Key Takeaways
Revenue grew 4.79% annually over 5 years — modest growth
Earnings declined -21.97% over the past year
Generating 1.47B in free cash flow
Cash machine — converts 208.81% of earnings into free cash flow
Capital efficient — spends only 2.73% of revenue on capex
Growth
Revenue Growth (5Y)
4.79%
Revenue (1Y)7.20%
Earnings (1Y)-21.97%
FCF Growth (3Y)11.37%
Quality
Return on Equity
5.60%
ROIC5.05%
Net Margin8.57%
Op. Margin16.55%
Safety
Debt / Equity
0.59
Current Ratio1.98
Interest Coverage4.65
Valuation
P/E Ratio
24.67
P/B Ratio1.37
EV/EBITDA17.86
Dividend Yield0.01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 7.20% | Revenue Growth (3Y) | 5.51% |
| Earnings Growth (1Y) | -21.97% | Earnings Growth (3Y) | -17.01% |
| Revenue Growth (5Y) | 4.79% | Earnings Growth (5Y) | 15.11% |
| Profitability | |||
| Revenue (TTM) | 8.23B | Net Income (TTM) | 705.20M |
| ROE | 5.60% | ROA | 3.05% |
| Gross Margin | 61.62% | Operating Margin | 16.55% |
| Net Margin | 8.57% | Free Cash Flow (TTM) | 1.47B |
| ROIC | 5.05% | FCF Growth (3Y) | 11.37% |
| Safety | |||
| Debt / Equity | 0.59 | Current Ratio | 1.98 |
| Interest Coverage | 4.65 | Dividend Yield | 0.01% |
| Valuation | |||
| P/E Ratio | 24.67 | P/B Ratio | 1.37 |
| P/S Ratio | 2.11 | PEG Ratio | -1.26 |
| EV/EBITDA | 17.86 | Dividend Yield | 0.01% |
| Market Cap | 17.40B | Enterprise Value | 24.33B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 8.23B | 7.68B | 7.39B | 6.94B | 6.83B |
| Net Income | 705.20M | 903.80M | 1.02B | 231.40M | 401.60M |
| EPS (Diluted) | 3.55 | 4.43 | 4.88 | 1.10 | 1.91 |
| Gross Profit | 5.07B | 5.49B | 5.31B | 4.92B | 4.87B |
| Operating Income | 1.36B | 1.29B | 1.28B | 696.30M | 860.30M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 23.09B | 21.37B | 21.50B | 21.07B | 23.46B |
| Total Liabilities | 10.39B | 8.89B | 9.01B | 9.04B | 10.79B |
| Shareholders' Equity | 12.71B | 12.47B | 12.48B | 12.02B | 12.66B |
| Total Debt | 7.52B | 6.20B | 5.77B | 5.70B | 7.07B |
| Cash & Equivalents | 591.90M | 525.50M | 415.80M | 375.70M | 378.10M |
| Current Assets | 5.12B | 4.67B | 4.61B | 4.43B | 4.89B |
| Current Liabilities | 2.58B | 2.45B | 2.86B | 2.36B | 3.47B |
Strategy Scores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#335 of 1024
Recent Activity
Entered
Cash Flow Compounder
Mar 24, 2026